AEGON Asset Management (UK)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
AEGON Asset Management (UK)'s LLY Position: Q2 2026 in Review
AEGON Asset Management (UK) increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $17.4M and bringing the position to 81,026 shares worth $97.2M. The position accounts for 1.04% of the portfolio, ranked #23.
AEGON Asset Management (UK) first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- AEGON Asset Management (UK) held 81,026 shares of Eli Lilly worth $97.2M as of Q2 2026.
- AEGON Asset Management (UK) bought 17,035 Eli Lilly shares in Q2 2026, an estimated $17.4M.
- Eli Lilly made up 1.04% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #23 holding.
- AEGON Asset Management (UK) first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.